Tag: its-advisory
-
U.S. FDA panel narrowly backs Cempra’s antibiotic solithromycin
The effectiveness of Cempra Inc’s antibiotic to treat community-acquired pneumonia outweighs the risk of liver injury, an advisory panel to the U.S. Food and Drug Administration narrowly concluded on Friday. The panel voted 7-6 that the drug, solithromycin, should be approved to treat the kind of pneumonia that recently affected U.S. presidential candidate Hillary Clinton.…